Symbiotec Pharmalab IPO listing: listed at ₹988, flat at the issue price
Symbiotec Pharmalab listed on NSE, BSE on 1 Sep 2026 at ₹988 per share, ₹0 (0.0%) against the upper price band of ₹988. The issue (price band ₹988, bidding 24 Aug 2026 to 27 Aug 2026) was subscribed 75.08x overall. The last grey-market premium we captured before listing was ₹212 on 31 Aug 2026 (daily average of 10 quotes), which implied a listing price of ₹1,200; the shares listed at ₹988, ₹212 below that.
Updated 6 Oct 2026, 19:02 IST. Dated dealer references.
Listing day facts
| Listing date | 1 Sep 2026 |
|---|---|
| Exchange | NSE, BSE |
| Listing price | ₹988 |
| Upper price band (issue price basis) | ₹988 |
| Gain or loss vs upper band | ₹0 per share (0.0%) |
| Price band | ₹988 |
| Issue dates | 24 Aug 2026 to 27 Aug 2026 |
| Subscription (overall, at close) | 75.08x, as of 27 Aug 2026 |
| Lot size | 15 shares |
| Gain or loss per lot vs upper band | ₹0 |
Grey-market premium against the actual listing
The last grey-market premium we captured before listing was ₹212 on 31 Aug 2026 (daily average of 10 quotes), which implied a listing price of ₹1,200; the shares listed at ₹988, ₹212 below that.
| Date | GMP | Implied listing price | Actual listing vs implied | Quotes captured |
|---|---|---|---|---|
| 19 Aug 2026 | ₹192 | ₹1,180 | −₹192 (−16.3%) | 5 |
| 20 Aug 2026 | ₹244 | ₹1,232 | −₹244 (−19.8%) | 11 |
| 21 Aug 2026 | ₹324 | ₹1,312 | −₹324 (−24.7%) | 13 |
| 22 Aug 2026 | ₹368 | ₹1,356 | −₹368 (−27.1%) | 12 |
| 23 Aug 2026 | ₹409 | ₹1,397 | −₹409 (−29.3%) | 10 |
| 24 Aug 2026 | ₹396 | ₹1,384 | −₹396 (−28.6%) | 12 |
| 25 Aug 2026 | ₹344 | ₹1,332 | −₹344 (−25.8%) | 5 |
| 26 Aug 2026 | ₹330 | ₹1,318 | −₹330 (−25.0%) | 5 |
| 27 Aug 2026 | ₹271 | ₹1,259 | −₹271 (−21.5%) | 9 |
| 28 Aug 2026 | ₹264 | ₹1,252 | −₹264 (−21.1%) | 9 |
| 29 Aug 2026 | ₹249 | ₹1,237 | −₹249 (−20.1%) | 13 |
| 30 Aug 2026 | ₹240 | ₹1,228 | −₹240 (−19.5%) | 10 |
| 31 Aug 2026 | ₹212 | ₹1,200 | −₹212 (−17.7%) | 10 |
GMP is unofficial and unregulated; these are the quotes our desk feed captured, averaged by day. Only the price band and the exchange listing price are official.
Frequently asked questions
What was the Symbiotec Pharmalab IPO listing price?
Symbiotec Pharmalab listed on NSE, BSE on 1 Sep 2026 at ₹988 per share.
How did Symbiotec Pharmalab list against the issue price?
The listing price of ₹988 was ₹0 per share (0.0%) against the upper price band of ₹988.
What did the grey market indicate before Symbiotec Pharmalab listed?
The last grey-market premium we captured before listing was ₹212 on 31 Aug 2026 (daily average of 10 quotes), which implied a listing price of ₹1,200; the shares listed at ₹988, ₹212 below that. GMP is unofficial and not a forecast.
Where do Symbiotec Pharmalab shares trade now?
On NSE, BSE. Check the exchange for the current quote; BuyUnlistedShares tracks unlisted shares and does not quote listed prices.
Symbiotec Pharmalab IPO overview · GMP history · Subscription status · Allotment status
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP, in the market since 2002. Reviewed by the BuyUnlistedShares desk before publishing. Data as of 06 Oct 2026.
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Ask · Community · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
Part of the Gayatri Financial Synergy group (gayatrifin.com): AMFI-registered mutual fund distributor, Faridabad, since 2002.
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
